Brevan Howard Capital Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$225K	Sell	65,607 -75,718	-54%	-$260K	﹤0.01%	1579
2025 Q1	$315K	Buy	141,325 +57,806	+69%	+$129K	﹤0.01%	806
2024 Q4	$245K	Buy	83,519 +70,633	+548%	+$207K	﹤0.01%	816
2024 Q3	$33.5K	Buy	+12,886	New	+$33.5K	﹤0.01%	1045